Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Insight Molecular Diagnostics Inc. - Common Stock (NQ:IMDX)

3.870 -0.150 (-3.73%)
Streaming Delayed Price Updated: 11:16 AM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,568
Open 4.030
Bid (Size) 3.850 (2,000)
Ask (Size) 3.880 (300)
Prev. Close 4.020
Today's Range 3.860 - 4.205
52wk Range 2.420 - 8.510
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Transcript: Insight Molecular Q2 2026 Earnings Conference Call ↗
Insight Molecular (NASDAQ:IMDX) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings... 
Via Benzinga
Topics Earnings
News headline image
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript ↗
FDA review nears completion as reimbursement rates support commercial launch. 
Via The Motley Fool
Topics Earnings

Performance

YTD
-45.9%
-45.9%
1 Month
-9.4%
-9.4%
3 Month
-27.3%
-27.3%
6 Month
-14.6%
-14.6%
1 Year
+25.2%
+25.2%

More News

Read More
News headline image
Oncocyte Eyes Faster, Less Invasive Heart Transplant Rejection Testing ↗
Via MarketBeat
News headline image
Oncocyte Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Insight Molecular Diagnostics (NASDAQ:IMDX) Soars on 285% Revenue Beat and Key FDA Submission ↗
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
Via Benzinga
News headline image
Exploring Insight Molecular's Earnings Expectations ↗
Via Benzinga
News headline image
IMDX Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
These stocks are moving in today's session ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
INSIGHT MOLECULAR DIAGNOSTIC (NASDAQ:IMDX) Stock Plummets 11.8% on Q3 Earnings Miss ↗
Via Chartmill
News headline image
A Look at Insight Molecular's Upcoming Earnings Report ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2025 ↗
Via Benzinga

Frequently Asked Questions

Is Insight Molecular Diagnostics Inc. - Common Stock publicly traded?
Yes, Insight Molecular Diagnostics Inc. - Common Stock is publicly traded.
What exchange does Insight Molecular Diagnostics Inc. - Common Stock trade on?
Insight Molecular Diagnostics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insight Molecular Diagnostics Inc. - Common Stock?
The ticker symbol for Insight Molecular Diagnostics Inc. - Common Stock is IMDX on the Nasdaq Stock Market
What is the current price of Insight Molecular Diagnostics Inc. - Common Stock?
The current price of Insight Molecular Diagnostics Inc. - Common Stock is 3.870
When was Insight Molecular Diagnostics Inc. - Common Stock last traded?
The last trade of Insight Molecular Diagnostics Inc. - Common Stock was at 09/16/26 11:16 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.